Versartis Inc (VSAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VSAR | PSNL | ACST | ||
| Company | Versartis Inc | Personalis Inc | Acasti Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.22 | 1.2800 | 2.81 | ||
| High | 1.30 | 1.3062 | 2.91 | ||
| Low | 1.18 | 1.2300 | 2.81 | ||
| Last | 1.19 | 1.2600 | 2.85 | ||
| Change | -0.02 | -0.0300 | -0.02 | ||
| % Change | -1.65% | -2.33% | -0.70% | ||
| Volume | 349,900 | 203,100 | 9,800 | ||
| 20-Day Average Volume | 237,635 | 233,260 | 29,665 | ||
| Previous Close | 1.21 | 1.2900 | 2.87 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.37 | 1.3548 | 3.32 | ||
| 20-Day Raw Stochastic | 10.87% | 22.22% | 5.80% | ||
| 20-Day Relative Strength | 32.11% | 41.88% | 29.60% | ||
| Weighted Alpha | -62.20 | -65.94 | -31.20 | ||
| Today's Opinion | N/A | 88% Sell | 48% Buy | ||
| Previous Opinion | N/A | 72% Sell | 56% Buy | ||
| Last Month's Opinion | N/A | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.46% since 10/08/18 | unch since 04/15/24 | -15.18% since 04/15/24 | ||
| Low | 1.14 on 10/12/18 | 1.1800 on 04/18/24 | 2.81 on 04/22/24 | ||
| High | 1.36 on 10/10/18 | 1.3200 on 04/17/24 | 3.39 on 04/16/24 | ||
| 1-Month | |||||
| %Chg | -17.93% since 09/14/18 | -11.27% since 03/22/24 | -16.18% since 03/22/24 | ||
| Low | 1.14 on 10/12/18 | 1.1800 on 04/18/24 | 2.81 on 04/22/24 | ||
| High | 1.60 on 09/27/18 | 1.5400 on 04/01/24 | 3.50 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | -41.95% since 07/13/18 | -21.74% since 01/22/24 | +20.76% since 01/22/24 | ||
| Low | 1.14 on 10/12/18 | 1.1200 on 02/08/24 | 2.25 on 02/05/24 | ||
| High | 2.10 on 07/24/18 | 1.8000 on 03/13/24 | 3.59 on 02/22/24 | ||
| 6-Month | |||||
| %Chg | -26.77% since 04/13/18 | +32.97% since 10/20/23 | +17.28% since 10/20/23 | ||
| Low | 1.14 on 10/12/18 | 0.8906 on 11/10/23 | 1.98 on 01/17/24 | ||
| High | 2.55 on 06/18/18 | 2.3800 on 12/28/23 | 3.59 on 02/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 43,126 | 65,150 | 26,976 | ||
| Shares Outstanding, K | 36,240 | 50,504 | 9,399 | ||
| Annual Sales | 40,000,000 | 73,480,000 | 0 | ||
| Annual Net Income | -84,980,000 | -108,300,000 | -42,430,000 | ||
| Last Quarter Sales | N/A | 19,680,000 | 0 | ||
| Last Quarter Net Income | N/A | -26,580,000 | -2,390,000 | ||
| 60-Month Beta | 1.94 | 1.95 | 1.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 10/26/17 | -0.46 on 02/28/24 | -0.21 on 02/12/24 | ||
| Latest Earnings Date | 10/25/18 | 05/01/24 | 02/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||